A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 4,509 shares of HALO stock, worth $212,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,509
Previous 6,050 25.47%
Holding current value
$212,644
Previous $316,000 18.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$51.3 - $64.42 $79,053 - $99,271
-1,541 Reduced 25.47%
4,509 $257,000
Q2 2024

Aug 08, 2024

BUY
$37.81 - $52.4 $228,750 - $317,020
6,050 New
6,050 $316,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.